about
Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelinesHepatitis B and hepatitis C viral infections in patients with chronic lymphocytic leukemiaHepatitis B testing and vaccination in immigrants attending English as a second language classes in British Columbia, Canada.Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening.Hepatitis B among Inuit: A review with focus on Greenland InuitReassessing the role for lamivudine in chronic hepatitis B infection: a four-year cohort analysis.Hepatitis B screening before chemotherapy: a survey of practitioners' knowledge, beliefs, and screening practices.An overview of cancer and beliefs about the disease in Indigenous people of Australia, Canada, New Zealand and the US.Prevalence and correlates of HIV and hepatitis B virus coinfection in Northern Alberta.Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment.Occult hepatitis B virus infection in a North American adult hemodialysis patient population.A mathematical model to study the effect of hepatitis B virus vaccine and antivirus treatment among the Canadian Inuit population.The practice pattern of hepatitis b testing in rheumatoid arthritis patients: A cross-national comparison between US and Taiwan.Cost effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B from a Canadian public payer perspective.The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy.
P2860
Q27000080-509C55B2-CEFB-48CB-B93B-02B6D64F28E7Q33810030-3F91CAE6-D10A-4F8A-A269-3DEC8C2FDDCEQ33821988-58E2E437-5240-4FD1-84C6-83EA230400A0Q33969253-BAB4F6FB-17F6-4C0B-984D-883C3A1E7189Q35429416-E1813C81-2434-4633-A52E-E09865001470Q35626787-9015472E-02B3-451A-8D36-D410AB9E96DAQ35821198-1FBFC287-0C39-4DDE-9F5E-1131183BECF7Q36406054-DDFA2515-90B1-4B9F-8186-D2E0D51395BAQ37469327-C7F05C63-2800-4FD7-B288-98DFB9AF4731Q37632401-097AF687-E89B-4FBE-B819-38872B691BA5Q38844564-122DBF3E-8BAF-4AD2-825A-0E408EC5F0A0Q38996149-6B09689F-217E-49CA-9481-653643E8E410Q39697790-6661F65B-D3D3-40B6-A190-A1C2207653D9Q39930065-5CE7FAB0-9248-4A86-9794-F3E0A1F30A45Q40284619-B403CE09-041A-4B4A-9298-9B35DB8786A5Q45891915-18FCFDDC-2563-4A91-AA01-1194FEEC8433Q51261488-CBE1B2C1-916C-4F50-AE3F-BBD9ED6703C5
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Chronic hepatitis B infection in Canada.
@ast
Chronic hepatitis B infection in Canada.
@en
type
label
Chronic hepatitis B infection in Canada.
@ast
Chronic hepatitis B infection in Canada.
@en
prefLabel
Chronic hepatitis B infection in Canada.
@ast
Chronic hepatitis B infection in Canada.
@en
P2860
P356
P1476
Chronic hepatitis B infection in Canada.
@en
P2093
P2860
P304
P356
10.1155/2001/650313
P407
P577
2001-11-01T00:00:00Z